Gene Editing

Shares of Editas Medicine Inc (NASDAQ: EDIT) tumbled 20 percent Tuesday after the CEO of the genome editing company announced her resignation. Editas said Katrine Bosley will step down as president, CEO and board member while board member Cynthia Collins will run the company as interim CEO. The...

Shares of Crispr Therapeutics AG (NASDAQ: CRSP) fell more than 7 percent Thursday morning after the U.S. Food and Drug Administration said it placed a clinical hold on the company's therapy. What Happened The FDA placed a clinical hold on the Investigational New Drug application for Crispr...

Shares of Calyxt Inc (NASDAQ: CLXT) gained more than 7 percent Monday after analysts at BMO Capital Markets initiated coverage of the food and agriculture company with a bullish rating. The firm's Kenneth Zaslow slapped an Outperform rating on Calyxt's stock with a $32 price target. Calyxt is...